Articles in Accreditation & Quality Compliance Advisor - Volume 14 Issue 31
New research has linked several factors with risk of death in critically ill patients with coronavirus disease 2019 (COVID-19).
Think the results of your last Joint Commission survey were hard to understand? If CMS has their way, it may get murkier.
The blood test, Called PanSeer, detected cancer in 91% of people who had been asymptomatic when the samples were collected and were diagnosed with cancer one to four years later.
The prevalence of antibodies for people recovering from a mild cases of COVID-19 dropped precipitously after less than three months, according to a research letter published this week in The New England Journal of Medicine.